IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $13,000 | 0.0% | 359 | 0.0% | 0.00% | – |
Q1 2022 | $13,000 | +18.2% | 359 | 0.0% | 0.00% | – |
Q4 2021 | $11,000 | -94.8% | 359 | -94.3% | 0.00% | -100.0% |
Q3 2021 | $210,000 | -32.3% | 6,249 | -19.7% | 0.00% | -50.0% |
Q2 2021 | $310,000 | -86.2% | 7,783 | -84.4% | 0.00% | -85.7% |
Q1 2021 | $2,240,000 | -6.5% | 49,825 | +17.6% | 0.01% | -6.7% |
Q4 2020 | $2,395,000 | +332.3% | 42,363 | +262.9% | 0.02% | +275.0% |
Q3 2020 | $554,000 | -73.4% | 11,672 | -66.9% | 0.00% | -78.9% |
Q2 2020 | $2,080,000 | +352.2% | 35,277 | +262.9% | 0.02% | +280.0% |
Q1 2020 | $460,000 | +14.7% | 9,721 | +46.3% | 0.01% | +66.7% |
Q4 2019 | $401,000 | +23.8% | 6,646 | +22.7% | 0.00% | 0.0% |
Q3 2019 | $324,000 | -82.8% | 5,415 | -81.6% | 0.00% | -83.3% |
Q2 2019 | $1,887,000 | +202.9% | 29,364 | +282.5% | 0.02% | +200.0% |
Q1 2019 | $623,000 | +56.5% | 7,676 | +4.3% | 0.01% | +50.0% |
Q4 2018 | $398,000 | +4.7% | 7,359 | 0.0% | 0.00% | +33.3% |
Q3 2018 | $380,000 | +1210.3% | 7,359 | +1126.5% | 0.00% | – |
Q4 2016 | $29,000 | -39.6% | 600 | -53.8% | 0.00% | -100.0% |
Q3 2016 | $48,000 | +60.0% | 1,300 | 0.0% | 0.00% | – |
Q2 2016 | $30,000 | -43.4% | 1,300 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $53,000 | – | 1,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |